Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

NCT01854775 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Immune Deficiency Syndrome (AIDS)
HIV Infections

Interventions

DRUG: E/C/F/TAF
DRUG: E/C/F/TAF (Low Dose)

Sponsor

Gilead Sciences